Third-Party Testing Reputable suppliers provide Certificates of Analysis from independent laboratories verifying identity, purity, and sterility
Feature: Targets: Semaglutide: GLP-1 Tirzepatide: GLP-1 + GIP Retatrutide: GLP-1 + GIP + Glucagon Max Weight Loss: Semaglutide: ~15% Tirzepatide: ~22% Retatrutide: 24.2%+ Energy Expenditure: Semaglutide: Low Tirzepatide: Moderate Retatrutide: High Muscle Preservation: Semaglutide: Moderate Tirzepatide: Moderate Retatrutide: Better Dosing Frequency: All: Weekly The addition of glucagon receptor activation gives Retatrutide a unique fat-burning advantage, making it ideal for visceral fat reduction and metabolic reset protocols
Track changes and contact a provider for missed periods, persistent changes, postmenopausal bleeding, or severe symptoms
Semaglutide's data are built on over 25,000 participants across more than 20 randomized controlled trials, including the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication
Good news: there are other GLP-1 alternatives besides Ozempic that give you more options than you realize
